Rural counties in the U.S. are experiencing increasing rates of hepatocellular carcinoma incidence and mortality while urban ...

The study adds to growing evidence that immunotherapy and chemoembolization prolong progression-free survival.

Using the Chart Your Fart app, Australians self-reported an average of five flatus per day, with a higher number recorded among males versus females, at 5.2 versus 4.8. (JAMA Network Open) ...

GLP-1 drugs may reduce cancer progression and improve survival rates, according to recent studies presented at ASCO.

A three-drug regimen incorporating AstraZeneca's immune checkpoint inhibitors Imfinzi and Imjudo has reduced the risk of ...

Combining standard transarterial chemoembolization (TACE) with the immunotherapy-based STRIDE regimen improved ...

Bristol Myers secured EU approval for Opdivo plus AVD in newly diagnosed advanced cHL and advanced Camzyos' label expansion ...

Oral drug shows responses across 6 tumor types in patients resistant to immunotherapy, with durable benefits and manageable safety in a ...

Obesity has been associated with multiple gastrointestinal cancers, but patients with these malignancies and obesity who have ...

Across multiple solid tumors, GLP-1 RA initiation after cancer diagnosis is associated with reduced metastatic progression.

For more than two decades, transarterial chemoembolization (TACE) has served as the global standard of care for patients with ...